Effect of Beta-blockers on Extracranial Arteriovenous Malformations

Abstract is missing (Short communication)

[1]  N. Patel,et al.  Systematic review of pediatric mandibular arteriovenous malformations. , 2021, International journal of pediatric otorhinolaryngology.

[2]  Matthew A. Zapala,et al.  Monitoring Arteriovenous Malformation Response to Genotype-Targeted Therapy , 2020, Pediatrics.

[3]  C. Bodemer,et al.  Efficacy and Tolerance of Sirolimus (Rapamycin) for Extracranial Arteriovenous Malformations in Children and Adults. , 2019, Acta dermato-venereologica.

[4]  R. Ruiz-Rodríguez,et al.  Oral propranolol as palliative treatment for a recurrent arteriovenous malformation , 2019, Dermatologic therapy.

[5]  C. Shovlin,et al.  Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia , 2019, Orphanet Journal of Rare Diseases.

[6]  Jianyun Lu,et al.  Propranolol as a potentially novel treatment of arteriovenous malformations , 2018, JAAD case reports.

[7]  J. Mulliken,et al.  Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation. , 2017, American journal of human genetics.

[8]  D. Goga,et al.  Efficacy and safety of embolization in arteriovenous malformations of the extremities and head and neck: a retrospective study of 32 cases , 2015, European Journal of Dermatology.

[9]  Mary Wu Chang,et al.  A Randomized, Controlled Trial of Oral Propranolol for Infantile Hemangioma , 2015 .

[10]  C. Bernabéu,et al.  Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia , 2012, Thrombosis and Haemostasis.

[11]  J. Mulliken,et al.  Extracranial arteriovenous malformations: natural progression and recurrence after treatment. , 2010, Plastic and reconstructive surgery.

[12]  S. K. Sommers Smith,et al.  Beta blockade induces apoptosis in cultured capillary endothelial cells , 2002, In Vitro Cellular & Developmental Biology - Animal.

[13]  G. Steinberg,et al.  Arteriovenous Malformations , 1991 .